274 related articles for article (PubMed ID: 8765506)
41. In vitro antiproliferative activity of combinations of ether lipid analogues and DNA-interactive agents against human tumor cells.
Noseda A; Berens ME; White JG; Modest EJ
Cancer Res; 1988 Apr; 48(7):1788-91. PubMed ID: 3349458
[TBL] [Abstract][Full Text] [Related]
42. Synthesis and biological activity of 3'-deamino-3'-haloanthracyclines.
Demetzos C; Skaltsounis AL; Michel S; Tillequin F; Koch M; Anstett M; Leonce S; Pierré A; Atassi G
Anticancer Drug Des; 1994 Apr; 9(2):129-37. PubMed ID: 8166928
[TBL] [Abstract][Full Text] [Related]
43. Stereospecific synthesis of antitumor active thioether PAF analogs.
Bhatia SK; Hajdu J
Lipids; 1991 Dec; 26(12):1424-30. PubMed ID: 1819745
[TBL] [Abstract][Full Text] [Related]
44. Synthesis, structure, and biological activity of ferrocenyl carbohydrate conjugates.
Ferreira CL; Ewart CB; Barta CA; Little S; Yardley V; Martins C; Polishchuk E; Smith PJ; Moss JR; Merkel M; Adam MJ; Orvig C
Inorg Chem; 2006 Oct; 45(20):8414-22. PubMed ID: 16999442
[TBL] [Abstract][Full Text] [Related]
45. The antitumor ether lipid edelfosine (ET-18-O-CH3) induces apoptosis in H-ras transformed human breast epithelial cells: by blocking ERK1/2 and p38 mitogen-activated protein kinases as potential targets.
Na HK; Surh YJ
Asia Pac J Clin Nutr; 2008; 17 Suppl 1():204-7. PubMed ID: 18296338
[TBL] [Abstract][Full Text] [Related]
46. Small cell lung carcinoma exhibits greater phospholipase C-beta1 expression and edelfosine resistance compared with non-small cell lung carcinoma.
Strassheim D; Shafer SH; Phelps SH; Williams CL
Cancer Res; 2000 May; 60(10):2730-6. PubMed ID: 10825148
[TBL] [Abstract][Full Text] [Related]
47. Enantioselective synthesis and antiproliferative properties of an ilmofosine analog, 2'-(trimethylammonio)ethyl 3-(hexadecyloxy)-2-(methoxymethyl)propyl phosphate, on epithelial cancer cell growth.
Bittman R; Byun HS; Reddy KC; Samadder P; Arthur G
J Med Chem; 1997 Apr; 40(9):1391-5. PubMed ID: 9135036
[TBL] [Abstract][Full Text] [Related]
48. Increased generation of lipid-derived and ascorbate free radicals by L1210 cells exposed to the ether lipid edelfosine.
Wagner BA; Buettner GR; Burns CP
Cancer Res; 1993 Feb; 53(4):711-3. PubMed ID: 8428351
[TBL] [Abstract][Full Text] [Related]
49. A comparative study of the effect of the antineoplastic ether lipid 1-O-octadecyl-2-O-methyl-glycero-3-phosphocholine and some homologous compounds on PKC alpha and PKC epsilon.
Conesa-Zamora P; Mollinedo F; Corbalán-García S; Gómez-Fernández JC
Biochim Biophys Acta; 2005 Feb; 1687(1-3):110-9. PubMed ID: 15708359
[TBL] [Abstract][Full Text] [Related]
50. A 5'-(trifluoromethyl)anthracycline glycoside: synthesis of antitumor-active 7-O-(2,6-dideoxy-6,6,6-trifluoro-alpha-L-lyxo-hexopyranosyl) adriamycinone.
Takagi Y; Nakai K; Tsuchiya T; Takeuchi T
J Med Chem; 1996 Apr; 39(8):1582-8. PubMed ID: 8648597
[TBL] [Abstract][Full Text] [Related]
51. Inhibition of the signalling enzyme phosphatidylinositol-3-kinase by antitumor ether lipid analogues.
Berggren MI; Gallegos A; Dressler LA; Modest EJ; Powis G
Cancer Res; 1993 Sep; 53(18):4297-302. PubMed ID: 8395981
[TBL] [Abstract][Full Text] [Related]
52. The degradation of platelet-activating factor and related lipids: susceptibility to phospholipases C and D.
Wilcox RW; Wykle RL; Schmitt JD; Daniel LW
Lipids; 1987 Nov; 22(11):800-7. PubMed ID: 3444369
[TBL] [Abstract][Full Text] [Related]
53. Cell kill and cytostasis by ET-18-OCH3 and heat.
Fujiwara K; Modest EJ; Wallen CA
Anticancer Res; 1995; 15(4):1333-8. PubMed ID: 7654017
[TBL] [Abstract][Full Text] [Related]
54. Antiinvasive activity of hexadecylphosphocholine in vitro.
Schallier DC; Bruyneel EA; Storme GA; Hilgard P; Mareel MM
Anticancer Res; 1991; 11(3):1285-92. PubMed ID: 1888162
[TBL] [Abstract][Full Text] [Related]
55. Syntheses of racemic and nearly optically pure ether lipids and evaluation of in vitro antineoplastic activities.
Duclos RI; Chia HH; Abdelmageed OH; Esber H; Fournier DJ; Makriyannis A
J Med Chem; 1994 Nov; 37(24):4147-54. PubMed ID: 7990114
[TBL] [Abstract][Full Text] [Related]
56. Antiinvasive effect of racemic 1-O-octadecyl-2-O-methylglycero-3-phosphocholine on MO4 mouse fibrosarcoma cells in vitro.
Storme GA; Berdel WE; van Blitterswijk WJ; Bruyneel EA; De Bruyne GK; Mareel MM
Cancer Res; 1985 Jan; 45(1):351-7. PubMed ID: 4038380
[TBL] [Abstract][Full Text] [Related]
57. Effect of anti-tumor ether lipids on ordered domains in model membranes.
Heczková B; Slotte JP
FEBS Lett; 2006 May; 580(10):2471-6. PubMed ID: 16638573
[TBL] [Abstract][Full Text] [Related]
58. Inhibition of protein kinase C by ether-linked lipids is not correlated with their antineoplastic activity on WEHI-3B and R6X-B15 cells.
Salari H; Dryden P; Davenport R; Howard S; Jones K; Bittman R
Biochim Biophys Acta; 1992 Feb; 1134(1):81-8. PubMed ID: 1543759
[TBL] [Abstract][Full Text] [Related]
59. Role of endocytosis in the action of ether lipids on WEHI-3B, HL60, and FDCP-mix A4 cells.
Bazill GW; Dexter TM
Cancer Res; 1990 Dec; 50(23):7505-12. PubMed ID: 2253199
[TBL] [Abstract][Full Text] [Related]
60. Evaluation of the antitumor activity of 1-(3-C-ethynyl-beta-D-ribofuranosyl) (PJ272), a recent ribonucleoside analogue.
Holl V; Jung P; Weltin D; Dauvergne J; Burger A; Coelho D; Dufour P; Aubertin AM; Bischoff PL; Biellmann JF
Anticancer Res; 2000; 20(3A):1739-42. PubMed ID: 10928102
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
